Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating amyotrophy

A technology of muscle atrophy and composition, which is applied in the field of the treatment of muscle weakness and muscle atrophy, and the pharmaceutical composition for the treatment of muscle atrophy, which can solve the problems of low incidence, no medicine for the treatment of muscle atrophy, and the high price of Riluzole

Inactive Publication Date: 2004-12-29
HEBEI MIN SHENG MEDICAL RES INST
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Clinically, there is no exact understanding of the etiology and pathogenesis of muscle atrophy. Therefore, there is no effective western medicine therapy that can cure or prevent the development of the disease. The imported new drug Riluzole is expensive and has unsatisfactory curative effects. Traditional Chinese medicine treats muscle atrophy, Muscle diseases such as myasthenia are collectively referred to as atrophy. Due to the extremely low incidence of the disease, there is no medicine for treating muscle atrophy.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0280] 66. Astragalus 30g, American ginseng 10g, schisandra 10g, rehmannia glutinosa 15g, cinnamon 10g

[0281] Cornus 10g, Yam 12g, Sichuan Achyranthes bidentata 10g, Cuscuta 10g, Lycium barbarum 15g

[0282] Morinda officinalis 10g Ziheche 8g Shanjia beads 10g Antler glue (melted) 10g

[0283] Vinegar tortoiseshell 10g Salvia 10g Chenpi 10g Bupleurum 10g Angelica 10g

[0284] Malt 10g Hawthorn Meat 10g Divine Comedy 12g

[0285] 67. Astragalus 30g, American ginseng 10g, Schisandra 12g, rehmannia glutinosa 15g, cinnamon 10g

[0286] Cornus 10g, Yam 12g, Sichuan Achyranthes bidentata 15g, Cuscuta 10g, Lycium barbarum 15g

[0287] Morinda officinalis 10g Ziheche 8g Shanjia beads 10g Antler glue (melted) 10g

[0288] Vinegar tortoiseshell 10g Salvia 10g Chenpi 10g Bupleurum 10g Angelica 10g Eucommia 15g

[0289] 68. Astragalus 30g, American ginseng 10g, schisandra 10g, rehmannia glutinosa 15g, cinnamon 10g

[0290] Cornus 10g, Yam 15g, Sichuan Achyranthes bidentata 10g, Cu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is one kind of muscular atrophy treating medicine composition capable of dredging meridian, promoting blood circulation to disperse blood clots, eliminating external evil, invigorating spleen and kidney, raising body's immunity and reaching Yin-Yang balance. It is prepared with eight kinds of Chinese medicinal materials, including astragalus root, cassia, human placenta, schisandra, antler glue, etc. and through dispersing antler glue in boiling water, heating the medicine materials with water at 120 deg.c and 1.2-1.5 atm for 30-40 min to obtain medicine liquid, and packing. The present invention can regenerate necrotic muscle molecule to reach the aim of curing muscular atrophy.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating muscle atrophy, belongs to the technical field of Chinese herbal medicine preparations, and is especially suitable for clinically treating muscle weakness and muscle atrophy. Background technique [0002] Clinically, there is no exact understanding of the etiology and pathogenesis of muscle atrophy. Therefore, there is no effective western medicine therapy that can cure or prevent the development of the disease. The imported new drug Riluzole is expensive and has unsatisfactory curative effects. Traditional Chinese medicine treats muscle atrophy, Muscle diseases such as myasthenia are collectively referred to as flaccidity. Due to the extremely low incidence of the disease, there is no medicine for treating muscle atrophy. Contents of the invention [0003] The purpose of the present invention is to open the meridians, promote blood circulation and remove blood stasis first, remove ex...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61P21/00
Inventor 李宏烨常振刚李树君柏怀仁
Owner HEBEI MIN SHENG MEDICAL RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com